Anthera Pharmaceuticals (ANTH) Financial Statements

238 Followers

Anthera Pharmaceuticals Financial Overview

Anthera Pharmaceuticals's market cap is currently $2.62K. The company's EPS TTM is $-0.47; its P/E ratio is ―; Anthera Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 17
Income Statement
Total Revenue	$ 0.00
Gross Profit	$ -281.00K
Operating Income	$ -36.43M
EBITDA	$ -26.59M
Net Income	$ -16.93M
Balance Sheet
Cash & Short-Term Investments	$ 2.20M
Total Assets	$ 3.67M
Total Debt	$ 0.00
Net Debt	$ -2.20M
Total Liabilities	$ 9.17M
Stockholders' Equity	$ -5.50M
Cash Flow
Free Cash Flow	$ -36.90M
Operating Cash Flow	$ -36.90M
Investing Cash Flow	$ 0.00
Financing Cash Flow	$ 18.25M

Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

Income Statement >

Anthera Pharmaceuticals Debt to Assets

Balance Sheet >

Anthera Pharmaceuticals Cash Flow

Cash Flow >

Anthera Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >